Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health total Consolidated Operating Revenue (Reportable Segments) ($M)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
50,440
Period ended Sep 30, 2026
Change on a year earlier
+0.7%
50,087 in Q3 2025
History
40 quarters
Since Q4 2016
Sources
35
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Consolidated Operating Revenue (Reportable Segments) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 50,440 | +0.7% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 49,826 | +0.8% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 49,494 | +1.5% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 49,311 | +9.6% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2025 | Sep 30, 2025 | 50,087 | +12.0% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 49,421 | +14.3% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 48,765 | +15.4% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 44,989 | +6.0% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 44,719 | +5.3% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 43,223 | -0.4% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 42,273 | +0.9% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 42,454 | +7.0% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 42,480 | +7.2% | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 43,377 | +12.7% | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 41,898 | +10.6% | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 39,667 | +3.1% | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 39,625 | +11.5% | 8-K ER (FY2023Q3, 2023-10-18) ↗ |
| Q2 2022 | Jun 30, 2022 | 38,482 | +15.6% | 8-K ER (FY2023Q2, 2023-07-19) ↗ |
| Q1 2022 | Mar 31, 2022 | 37,886 | +18.0% | 8-K ER (FY2023Q1, 2023-04-19) ↗ |
| Q4 2021 | Dec 31, 2021 | 38,482 | +22.0% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 35,548 | +16.0% | 8-K ER (FY2022Q3, 2022-10-19) ↗ |
| Q2 2021 | Jun 30, 2021 | 33,279 | +14.1% | 8-K ER (FY2022Q2, 2022-07-20) ↗ |
| Q1 2021 | Mar 31, 2021 | 32,098 | +9.0% | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
| Q4 2020 | Dec 31, 2020 | 31,533 | +16.2% | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 30,649 | +15.9% | 8-K ER (FY2021Q3, 2021-10-20) ↗ |
| Q2 2020 | Jun 30, 2020 | 29,178 | +15.9% | 8-K ER (FY2021Q2, 2021-07-21) ↗ |
| Q1 2020 | Mar 31, 2020 | 29,448 | +20.7% | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
| Q4 2019 | Dec 31, 2019 | 27,132 | +16.4% | 8-K ER (FY2020Q4, 2021-01-27) ↗ |
| Q3 2019 | Sep 30, 2019 | 26,444 | +15.1% | 8-K ER (FY2020Q3, 2020-10-28) ↗ |
| Q2 2019 | Jun 30, 2019 | 25,177 | 0.0% | 8-K ER (FY2020Q2, 2020-07-29) ↗ |
| Q1 2019 | Mar 31, 2019 | 24,388 | +9.2% | 8-K ER (FY2020Q1, 2020-04-29) ↗ |
| Q4 2018 | Dec 31, 2018 | 23,304 | +2.6% | 8-K ER (FY2019Q4, 2020-01-29) ↗ |
| Q3 2018 | Sep 30, 2018 | 22,980 | +4.0% | 8-K ER (FY2019Q3, 2019-10-23) ↗ |
| Q2 2018 | Jun 30, 2018 | 25,177 | +13.4% | 8-K ER (FY2019Q2, 2019-07-24) ↗ |
| Q1 2018 | Mar 31, 2018 | 22,342 | +0.1% | 8-K ER (FY2019Q1, 2019-04-24) ↗ |
| Q4 2017 | Dec 31, 2017 | 22,715 | +5.7% | 8-K ER (FY2018Q4, 2019-01-30) ↗ |
| Q3 2017 | Sep 30, 2017 | 22,097 | – | 8-K ER (FY2018Q3, 2018-10-31) ↗ |
| Q2 2017 | Jun 30, 2017 | 22,198 | – | 8-K ER (FY2018Q2, 2018-07-25) ↗ |
| Q1 2017 | Mar 31, 2017 | 22,320 | – | 8-K ER (FY2018Q1, 2018-04-25) ↗ |
| Q4 2016 | Dec 31, 2016 | 21,485 | – | 8-K ER (FY2017Q4, 2018-01-31) ↗ |
Breakdown
What makes up total consolidated operating revenue (reportable segments)
Cite this data
StockData. (2026). Elevance Health Total Consolidated Operating Revenue (Reportable Segments) ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg_rev_consolidated_total
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.